Mergers & Acquisitions

  • May 28, 2025

    SunCoke Energy Expanding With $325M Phoenix Global Buy

    SunCoke Energy Inc. said Wednesday that it has agreed to acquire Phoenix Global, a privately held provider of metals and mining services, for $325 million on a cash-free, debt-free basis.

  • May 28, 2025

    DOJ Tells Justices American Airlines Can't Renew JetBlue Pact

    The federal government told the U.S. Supreme Court that the First Circuit correctly determined that American Airlines failed to prove at trial that its codeshare agreement with JetBlue in Boston and New York had procompetitive benefits, and the carrier's attempt to revive the alliance is moot anyway.

  • May 28, 2025

    Singapore's Quadria Closes $1B-Plus Healthcare Fund

    Singapore-based private equity firm Quadria Capital has closed its third healthcare fund at $1.07 billion, surpassing its $800 million target as it targets companies across Asia. 

  • May 28, 2025

    Anesthesiology Co. Urges Dismissal Of Antitrust Class Action

    U.S. Anesthesia Partners told a Houston judge that a patient leading a proposed class action accusing it of monopolizing the Texas anesthesia market doesn't have a valid claim because his insurance company chose how much he paid for services.

  • May 28, 2025

    Defense-Focused SPAC Leads Pair Of Listings Totaling $285M

    Defense- and aerospace-focused Kochav Defense Acquisition Corp. began trading Wednesday after pricing a $220 million initial public offering, one of two special purpose acquisition companies to join a recovering market after raising $285 million combined.

  • May 28, 2025

    Checkpoint Pharma Sued For Docs On $355M Merger Plan

    Stockholders of cancer drug developer Checkpoint Pharmaceuticals sued the company in Delaware's Chancery Court for documents on its proposed $355 million acquisition by India-based Sun Pharmaceuticals, alleging conflicts and lack of disclosures regarding the role played by Checkpoint's controlling investor, Fortress Biotech.

  • May 28, 2025

    In Volatile World, PE Attys Guide Complex Take-Private Deals

    As rising geopolitical tensions and tariff uncertainty continue to rattle dealmaking markets, attorneys are guiding private equity firms and potential take-private targets through increasingly complex negotiations.

  • May 28, 2025

    Freshfields Gains New Tech M&A Leadership From Debevoise

    Freshfields LLP announced Wednesday that it has hired a former Debevoise & Plimpton LLP attorney in San Francisco to co-lead its U.S. tech and life sciences mergers and acquisitions practice.

  • May 28, 2025

    Kirkland Hires 3 M&A Partners From Skadden

    Kirkland & Ellis LLP announced Wednesday the addition of a three-partner mergers and acquisition team from Skadden Arps Slate Meagher & Flom LLP, among dozens of new hires made by the firm this week.

  • May 28, 2025

    Audacy Gig Squelched By Soros Fund, Radio Executive Says

    A Connecticut radio executive who claims he played a key role in Soros Fund Management LLC's acquisition of Audacy Inc. is suing the fund and one of its leaders, saying he was boxed out of an alleged deal to become CEO or receive a 5% cut of the fund's profits.

  • May 27, 2025

    Kirkland, Cravath Steer WiseTech's $2.1B Merger With E2open

    Kirkland & Ellis LLP advised cloud-based software platform E2open Parent Holdings Inc. in its $2.1 billion merger with logistics software provider WiseTech Global Ltd., which is being advised by Cravath Swaine & Moore LLP, according to an announcement made Tuesday.

  • May 27, 2025

    Chancery Footnotes Raise Post-SB 21 Stir In Delaware

    A Delaware vice chancellor has created a stir with expansive opinion footnotes pushing back on the state Supreme Court's rejection of a controller's liability to stockholders after rechartering a business in more board-friendly Nevada, close on the heels of a bitter legislative debate over reworking Delaware corporate law.

  • May 27, 2025

    Bankrupt 23andMe To Delist Stock After Regeneron Deal

    Bankrupt genetic testing provider 23andMe Inc. said Tuesday it will delist its stock from the Nasdaq exchange, following Regeneron Pharmaceuticals Inc.'s agreement last week to buy the defunct company.

  • May 27, 2025

    Judge Follows The Users And The Money In Meta's FTC Case

    A D.C. federal judge on Tuesday looked for the right metrics to measure the effect that Meta Platforms Inc. has had on Instagram and WhatsApp in terms of users, growth and money spent buying the apps in deals the Federal Trade Commission says were designed to buy or bury the competition.

  • May 27, 2025

    DOJ Wants Google Docs Analyzing Potential Ad Tech Breakup

    Enforcers are asking a Virginia federal court for access to Google documents analyzing a potential break up of the company's ad tech business, as the court considers what remedies to impose after finding Google monopolized key ad tech markets.

  • May 27, 2025

    Davis Polk-Led Stablecoin Giant Circle Eyes $600M IPO

    Venture-backed stablecoin issuer Circle Internet Group Inc. on Tuesday launched plans for an estimated $600 million initial public offering, represented by Davis Polk & Wardwell LLP and underwriters' counsel Skadden Arps Slate Meagher & Flom LLP, rekindling its IPO after a tariff-related pause.

  • May 27, 2025

    Trump's Media Co. To Raise $2.5B For Bitcoin Purchase

    Trump Media & Technology Group Corp., the parent company of President Donald Trump's social media platform, said Tuesday it plans to raise $2.5 billion from institutional investors to buy bitcoin to create what it is calling a bitcoin treasury.

  • May 27, 2025

    Morgan Lewis Guides NYC's $5B Equity Sale To Blackstone

    Morgan Lewis & Bockius LLP has helped guide the New York City pension system's sale of $5 billion of private equity holdings to Blackstone Inc. in a transaction that the city says is one of the nation's largest ever pension-led secondary sales of its kind.

  • May 27, 2025

    Paris VC Firm Cathay Closes $1B AI Venture Capital Fund

    Paris venture capital firm Cathay Innovation said Tuesday that it has closed a $1 billion fund focused on artificial intelligence investments.

  • May 27, 2025

    Nikola Creditors Ask To Examine Founder Over $100M Award

    The creditors committee in Nikola Corp.'s Chapter 11 case has asked a Delaware bankruptcy court for permission to conduct discovery on the company's founder to investigate whether he is dissipating personal assets that should be used to satisfy a $100 million arbitration award owed to the debtor.

  • May 27, 2025

    Salesforce To Buy Informatica In $8B Deal Led By 4 Firms

    Salesforce announced plans Tuesday to purchase cloud data management company Informatica in an $8 billion deal overseen by Latham & Watkins LLP, Wachtell Lipton Rosen & Katz, Fenwick & West LLP and Morrison & Foerster LLP.

  • May 27, 2025

    Eli Lilly Inks $1B Deal For Non-Opioid Pain-Drug Maker

    Eli Lilly announced Tuesday that it has inked a potentially $1 billion deal to buy SiteOne Theraputics, giving the pharmaceutical giant access to a non-opiod pain medicine ready for phase 2 trials. 

  • May 27, 2025

    Slaughter And May-Led Bain Invests £120M In UK Finance Biz

    U.S. investment business Bain Capital has taken a stake worth nearly 30% in The Openwork Partnership for £120 million ($163 million) after winning backing from the City watchdog, the British financial adviser said Tuesday.

  • May 27, 2025

    Energy Consultancy Backs PE Firm's 'Superior' £129M Bid

    Energy and sustainability consultancy Inspired PLC said Tuesday that it intends to back a "superior" takeover bid of £129 million ($175 million) tabled by private equity firm HGGC after rejecting a "wholly inadequate" £109 million offer from Regent International, a gas and metering services business.

  • May 27, 2025

    Serco Completes $327M Northrop Defense Biz Deal

    British conglomerate Serco Group PLC said Tuesday that its U.S. subsidiary has finalized the acquisition of Northrop Grumman Corp.'s mission training and satellite communications business, known as MT&S, for $327 million after winning regulatory approval.

Expert Analysis

  • Making The Case For Rest In The Legal Profession

    Author Photo

    For too long, a culture of overwork has plagued the legal profession, but research shows that attorneys need rest to perform optimally and sustainably, so legal organizations and individuals must implement strategies that allow for restoration, says Marissa Alert at MDA Wellness, Carol Ross-Burnett at CRB Global, and Denise Robinson at The Still Center.

  • 4 Ways Women Attorneys Can Build A Legal Legacy

    Author Photo

    This Women’s History Month, women attorneys should consider what small, day-to-day actions they can take to help leave a lasting impact for future generations, even if it means mentoring one person or taking 10 minutes to make a plan, says Jackie Prester, a former shareholder at Baker Donelson.

  • A Judge's Pointers For Adding Spice To Dry Legal Writing

    Author Photo

    U.S. District Judge Fred Biery shares a few key lessons about how to go against the grain of the legal writing tradition by adding color to bland judicial opinions, such as by telling a human story and injecting literary devices where possible.

  • Preparing For Disruptions To Life Sciences Supply Chains

    Author Photo

    Life sciences companies must assess how new and escalating tariffs — combined with other restrictions on cross-border activity singling out pharmaceutical products and medical devices — will affect supply chains, and they should proactively prepare for antitrust and foreign direct investment regulatory review processes, say attorneys at Weil.

  • Mastering The Fundamentals Of Life Sciences Due Diligence

    Author Photo

    As life sciences transactions continue to gain tremendous momentum, companies participating in these transactions must conduct effective and strategic regulatory due diligence, which involves extensive amounts of information and varies by manifold factors, says Anna Zhao at GunnerCooke.

  • A Close-Up Look At DOJ's Challenge To HPE-Juniper Deal

    Author Photo

    The outcome of the Justice Department's challenge to Hewlett Packard Enterprise's proposed $14 billion acquisition of Juniper Networks will likely hinge on several key issues, including market dynamics and shares, internal documents, and questions about innovation and customer harm, say attorneys at McDermott.

  • 5 Merger Deal Considerations In Light Of The New HSR Rules

    Author Photo

    Now that the new Hart-Scott-Rodino Act rules are in effect, current priorities include earlier preparation for merging parties, certain confidentiality covenants, and key elements of letters of intent and term sheets, say attorneys at Fried Frank.

  • What FERC Scrutiny Of Directors, Assets Means For Investors

    Author Photo

    The Federal Energy Regulatory Commission has recently paid dramatically increased attention to appointments of power company directors by investors, and ownership of vertical assets that provide inputs for electric power production and sale — so investors in FERC-regulated entities should be paying more attention to these matters as well, say attorneys at Day Pitney.

  • Opinion

    Antitrust Analysis In Iowa Pathologist Case Misses The Mark

    Author Photo

    An Iowa federal court erred in its recent decision in Goldfinch Laboratory v. Iowa Pathology Associates by focusing exclusively on market impacts and sidestepping key questions that should be central to antitrust standing analysis, says Daniel Graulich at Baker McKenzie.

  • Anticipating Calif. Oversight Of PE Participation In Healthcare

    Author Photo

    A new bill recently introduced in the California Senate revives last year's attempt to increase oversight of healthcare transactions involving private equity groups and hedge funds, meaning that attorneys may soon need to assess the compliance status of existing management relationships and consider modifying contract terms, says Andrew Demetriou at Husch Blackwell.

  • When Reincorporation Out Of Del. Isn't A Good Idea

    Author Photo

    While recent high-profile corporate moves out of Delaware have prompted discussion about the benefits of incorporation elsewhere, for many, remaining in the First State may be the right decision due to its deep body of business law, tradition of nonjury trials and other factors, say attorneys at Goodwin.

  • New HSR Rules Augur A Deeper Antitrust Review By Agencies

    Author Photo

    After some initial uncertainty, the new Hart-Scott-Rodino Act rules did go into effect last month, and though their increased information requirements create greater initial burdens for merging parties, the rules should lead to greater certainty and predictability through a more efficient and effective review process, says Craig Malam at Edgeworth Economics.

  • Why Acquirers Should Reevaluate Federal Contract Risk

    Author Photo

    Long thought of as a stable investment, the scale with which the Trump administration is attempting to eliminate federal contracts is unprecedented, and acquirer considerations should include the size and scope of all active and pending government contracts of target companies, say attorneys at Winston & Strawn.

  • Opinion

    SEC Defense Bar Should Pursue Sanctions Flexibility Now

    Author Photo

    The U.S. Securities and Exchange Commission defense bar has an opening under the new administration to propose flexible, tailored sanctions that can substantially remediate misconduct and prevent future wrongdoing instead of onerous penalties, which could set sanctions precedent for years to come, says Josh Hess at BCLP.

  • 7 Tips For Associates To Thrive In Hybrid Work Environments

    Excerpt from Practical Guidance
    Author Photo

    As the vast majority of law firms have embraced some type of hybrid work policy, associates should consider a few strategies to get the most out of both their in-person and remote workdays, says James Argionis at Cozen O’Connor.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!